Press Releases June 4, 2026 07:00 AM

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations

Option Care Health appoints Robert Okunski as Vice President of Investor Relations to enhance investor communication and engagement.

By Maya Rios OPCH

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, announced the appointment of Robert Okunski as Vice President of Investor Relations. Okunski brings over 20 years of expertise in investor relations across healthcare and technology sectors and will lead the company's strategy to improve communication with the investment community and support its growth strategy.

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
OPCH

Key Points

  • Robert Okunski appointed as Vice President of Investor Relations effective May 26, 2026.
  • Okunski has extensive experience in investor relations across healthcare, technology, and energy sectors.
  • The role focuses on driving investor relations strategy, improving engagement, transparency, and corporate visibility.

BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026.

In this role, Okunski will lead the Company’s investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company’s business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders.

“Bob brings more than two decades of investor relations leadership experience across healthcare, technology and energy industries,” said Meenal Sethna, Chief Financial Officer of Option Care Health. “His proven track record of building best-in-class investor relations programs, strengthening investor engagement and enhancing transparency, elevating corporate visibility, will be invaluable as we continue to execute our growth strategy and create long-term shareholder value.”

Okunski joins Option Care Health from Enhabit Home Health & Hospice, where he served as Vice President of Investor Relations. During his tenure, he led the company’s investor relations strategy, enhanced engagement with institutional investors and analysts, and increased the company’s visibility within the investment community.

Prior to Enhabit, Okunski held senior investor relations leadership positions at Velo3D Inc., SunPower Corporation, Spansion Inc. and PeopleSoft.

Okunski holds a Master of Business Administration from Moravian University and a Bachelor of Arts from Colgate University.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.

For Investor Inquiries:

Bob OkunskiVice President, Investor [email protected]

Risks

  • The effectiveness of the new investor relations leadership in enhancing market perception remains uncertain.
  • Changing investor relations strategy might not immediately translate into tangible stock performance improvements.
  • Broader market or sector-specific conditions could overshadow benefits from enhanced investor outreach.

More from Press Releases

Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026 SOLV Energy Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares of Class A Common Stock Jun 4, 2026 NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option Jun 4, 2026 DLH Announces Filing of New Shelf Registration Statement Jun 4, 2026 FutureCorp Space Acquisition 1 Announces Pricing of $200,000,000 Initial Public Offering Jun 4, 2026